Clinical Efficacy: ATTAIN-1 Trial In the pivotal ATTAIN-1 trial, Foundayo showed weight loss of 12.4% at the highest dose over 72 weeks
Final Thoughts Before asking if glutathione harms your kidneys, ask: Is it regulated
Phase 2 trial data showed remarkable results, with participants losing up to 24% of body weight over 48 weeks at the highest dose
Anti-Inflammatory and Cytokine Regulation BPC-157 downregulates pro-inflammatory mediators including: Tumor Necrosis Factor-Alpha (TNF-) Interleukin-1 Beta (IL-1) Interleukin-6 (IL-6) Leukotrienes key drivers of pain and inflammation in arthritis and tendinopathy Growth Hormone Receptor Upregulation Emerging research suggests BPC-157 increases growth hormone receptor density in injured tissues, amplifying the natural repair signals that decline with age or chronic inflammation
Considerations: As with any copper-containing compound, there is a theoretical concern about copper toxicity with excessive systemic administration
Lower Heart Rate and Force: By blocking these hormones, they reduce the heart's workload, making it beat slower and with less force